A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
Completed
Bristol-Myers Squibb
Phase 2
The purpose of this study is to determine the efficacy of JNJ-70033093 in preventing total
venous thromboembolism (VTE) events (proximal and/or distal deep vein thrombosis [DVT]
[asymptomatic confirmed by venography assessment or objectively confirmed symptomatic],
nonfatal pulmonary embolism [PE], or any death) during the treatment period.
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
Completed
Janssen Research & Development, LLC
Phase 2
The purpose of this study is to determine the efficacy of JNJ-70033093 in preventing total
venous thromboembolism (VTE) events (proximal and/or distal deep vein thrombosis [DVT]
[asymptomatic confirmed by venography assessment or objectively confirmed symptomatic],
nonfatal pulmonary embolism [PE], or any death) during the treatment period.
A Study of JNJ-70033093 and Digoxin in Healthy Participants
Recruiting
Bristol-Myers Squibb
Phase 1
The purpose of this study is to evaluate the potential pharmacokinetic (PK) interaction
between JNJ-70033093 and digoxin in healthy participants after single dose administration and
at steady state.
A Study of JNJ-70033093 and Digoxin in Healthy Participants
Recruiting
Janssen Research & Development, LLC
Phase 1
The purpose of this study is to evaluate the potential pharmacokinetic (PK) interaction
between JNJ-70033093 and digoxin in healthy participants after single dose administration and
at steady state.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
